1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Electrolyte Chemistry Reagents - Pipeline Review, 2015

Electrolyte Chemistry Reagents - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Electrolyte Chemistry Reagents - Pipeline Review, 2015" provides an overview of Electrolyte Chemistry Reagents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrolyte Chemistry Reagents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Electrolyte Chemistry Reagents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Electrolyte Chemistry Reagents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Electrolyte Chemistry Reagents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Electrolyte Chemistry Reagents - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Electrolyte Chemistry Reagents Overview 5
3 Products under Development 6
3.1 Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development 6
3.2 Electrolyte Chemistry Reagents - Pipeline Products by Territory 7
3.3 Electrolyte Chemistry Reagents - Pipeline Products by Regulatory Path 8
3.4 Electrolyte Chemistry Reagents - Pipeline Products by Estimated Approval Date 9
4 Electrolyte Chemistry Reagents - Pipeline Products under Development by Companies 10
4.1 Electrolyte Chemistry Reagents Companies - Pipeline Products by Stage of Development 10
4.2 Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development 11
5 Electrolyte Chemistry Reagents Companies and Product Overview 12
5.1 Abbott Diagnostics Company Overview 12
5.1.1 Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 12
5.2 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 24
5.2.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 24
5.3 Analyticon Biotechnologies AG Company Overview 26
5.3.1 Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 26
5.4 Arizona State University Company Overview 31
5.4.1 Arizona State University Pipeline Products and Ongoing Clinical Trials Overview 31
5.5 ELITech Group Company Overview 33
5.5.1 ELITech Group Pipeline Products and Ongoing Clinical Trials Overview 33
5.6 NanoSpeed Diagnostics Inc. Company Overview 36
5.6.1 NanoSpeed Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
5.7 Vital Diagnostics, Inc. Company Overview 40
5.7.1 Vital Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
6 Electrolyte Chemistry Reagents- Recent Developments 42
7 Appendix 51
7.1 Methodology 51
7.2 About GlobalData 53
7.3 Contact Us 53
7.4 Disclaimer 53

1.1 List of Tables
Table 1: Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development 6
Table 2: Electrolyte Chemistry Reagents - Pipeline Products by Territory 7
Table 3: Electrolyte Chemistry Reagents - Pipeline Products by Regulatory Path 8
Table 4: Electrolyte Chemistry Reagents - Pipeline Products by Estimated Approval Date 9
Table 5: Electrolyte Chemistry Reagents Companies - Pipeline Products by Stage of Development 10
Table 6: Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development 11
Table 7: Abbott Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 12
Table 8: ARCHITECT c16000 System - Ca 72.2 Assay - Product Status 13
Table 9: ARCHITECT c16000 System - Ca 72.2 Assay - Product Description 13
Table 10: ARCHITECT c16000 System - Magnesium Enzymatic Assay - Product Status 14
Table 11: ARCHITECT c16000 System - Magnesium Enzymatic Assay - Product Description 14
Table 12: ARCHITECT c4000 - Magnesium Enzymatic Assay - Product Status 15
Table 13: ARCHITECT c4000 - Magnesium Enzymatic Assay - Product Description 15
Table 14: ARCHITECT c8000 - Magnesium Enzymatic Assay - Product Status 16
Table 15: ARCHITECT c8000 - Magnesium Enzymatic Assay - Product Description 16
Table 16: ARCHITECT c8000 System - Ca 72.2 Assay - Product Status 17
Table 17: ARCHITECT c8000 System - Ca 72.2 Assay - Product Description 17
Table 18: ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Status 18
Table 19: ARCHITECT ci16200 Integrated System - Ca 72.2 Assay - Product Description 18
Table 20: ARCHITECT ci16200 Integrated System - Magnesium Enzymatic Assay - Product Status 19
Table 21: ARCHITECT ci16200 Integrated System - Magnesium Enzymatic Assay - Product Description 19
Table 22: ARCHITECT ci4100 Integrated System - Ca 72.2 Assay - Product Status 20
Table 23: ARCHITECT ci4100 Integrated System - Ca 72.2 Assay - Product Description 20
Table 24: ARCHITECT ci4100 Integrated System - Magnesium Enzymatic Assay - Product Status 21
Table 25: ARCHITECT ci4100 Integrated System - Magnesium Enzymatic Assay - Product Description 21
Table 26: ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Status 22
Table 27: ARCHITECT ci8200 Integrated System - Ca 72.2 Assay - Product Description 22
Table 28: ARCHITECT ci8200 Integrated System - Magnesium Enzymatic Assay - Product Status 23
Table 29: ARCHITECT ci8200 Integrated System - Magnesium Enzymatic Assay - Product Description 23
Table 30: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 24
Table 31: ACE Axcel System - Calcium Assay - Product Status 25
Table 32: ACE Axcel System - Calcium Assay - Product Description 25
Table 33: Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 26
Table 34: Ammonium Lyophilisat - Product Status 27
Table 35: Ammonium Lyophilisat - Product Description 27
Table 36: Fluitest CA AIII - Product Status 28
Table 37: Fluitest CA AIII - Product Description 28
Table 38: Fluitest CA CPC - Product Status 29
Table 39: Fluitest CA CPC - Product Description 29
Table 40: Fluitest CL - Product Status 30
Table 41: Fluitest CL - Product Description 30
Table 42: Arizona State University Pipeline Products and Ongoing Clinical Trials Overview 31
Table 43: Diagnostic Assay - Osteoporosis - Product Status 32
Table 44: Diagnostic Assay - Osteoporosis - Product Description 32
Table 45: ELITech Group Pipeline Products and Ongoing Clinical Trials Overview 33
Table 46: Selectra ProM Chemistry System - Magnesium Assay - Product Status 34
Table 47: Selectra ProM Chemistry System - Magnesium Assay - Product Description 34
Table 48: Selectra ProS Chemistry System - Magnesium Assay - Product Status 35
Table 49: Selectra ProS Chemistry System - Magnesium Assay - Product Description 35
Table 50: NanoSpeed Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
Table 51: LFIA/Test4 Testing/Screening - Calcium - Product Status 37
Table 52: LFIA/Test4 Testing/Screening - Calcium - Product Description 37
Table 53: LFIA/Test4 Testing/Screening - Iron - Product Status 38
Table 54: LFIA/Test4 Testing/Screening - Iron - Product Description 38
Table 55: Test4Ca - Product Status 39
Table 56: Test4Ca - Product Description 39
Table 57: Vital Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 58: Eon 300 Automated Chemistry Analyzer - UIBC Assay - Product Status 41
Table 59: Eon 300 Automated Chemistry Analyzer - UIBC Assay - Product Description 41
Table 60: Glossary 52

1.2 List of Figures
Figure 1: Electrolyte Chemistry Reagents - Pipeline Products by Stage of Development 6
Figure 2: Electrolyte Chemistry Reagents - Pipeline Products by Territory 7
Figure 3: Electrolyte Chemistry Reagents - Pipeline Products by Regulatory Path 8
Figure 4: Electrolyte Chemistry Reagents - Pipeline Products by Estimated Approval Date 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016

Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • May 2016
  • by Global Markets Direct

Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

Nectar Lifesciences Ltd. (India)

Nectar Lifesciences Ltd. (India)

  • $ 3500
  • Company report
  • March 2016
  • by Global Industry Analysts

This report presents quick facts about Nectar Lifesciences Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 85 tables, the report showcases the company's sales performance, ...

Intage Holdings, Inc. (Japan)

Intage Holdings, Inc. (Japan)

  • $ 950
  • Company report
  • March 2016
  • by Global Industry Analysts

This report presents quick facts about Intage Holdings, Inc., which is principally involved in providing Marketing Research and Consulting; System Solutions; and Drug Development Solutions. Illustrated ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry - Company Report, January 2017

  • January 2017
    19 pages
  • Gastrointestina...  

    Therapy  

  • Netherlands  

    Europe  

View report >

OTC Industry - Analyst Report, January 2017

  • January 2017
    22 pages
  • Gastrointestina...  

  • United States  

    South Korea  

    Asia  

View report >

ALK Group - Investor Report, January 2017

  • January 2017
    25 pages
  • Respiratory Dis...  

    Asthma  

    Allergy Drug  

  • Europe  

    World  

    North America  

View report >

Related Market Segments :

Diagnostics
Mineral Supplement

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.